• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产碳青霉烯酶菌中国际高风险克隆的优势:来自印度的多中心分子流行病学报告

Dominance of international high-risk clones in carbapenemase-producing : Multicentric molecular epidemiology report from India.

作者信息

Pragasam Agila Kumari, Veeraraghavan Balaji, Anandan Shalini, Narasiman Vignesh, Sistla Sujatha, Kapil Arti, Mathur Purva, Ray Pallab, Wattal Chand, Bhattacharya Sanjay, Deotale Vijayashri, Subramani K, Peter J V, Hariharan T D, Ramya I, Iniyan S, Walia Kamini, Ohri V C

机构信息

Department of Clinical Microbiology, Christian Medical College, Vellore, Tamil Nadu, India.

Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

出版信息

Indian J Med Microbiol. 2018 Jul-Sep;36(3):344-351. doi: 10.4103/ijmm.IJMM_18_294.

DOI:10.4103/ijmm.IJMM_18_294
PMID:30429385
Abstract

BACKGROUND

Pseudomonas aeruginosa is one of the most common opportunistic pathogens that cause severe infections in humans. The burden of carbapenem resistance is particularly high and is on the rise. Very little information is available on the molecular mechanisms and its clonal types of carbapenem-resistant P. aeruginosa seen in Indian hospitals. This study was undertaken to monitor the β-lactamase profile and to investigate the genetic relatedness of the carbapenemase-producing (CP) P. aeruginosa collected across different hospitals from India.

MATERIALS AND METHODS

A total of 507 non-duplicate, carbapenem-resistant P. aeruginosa isolated from various clinical specimens collected during 2014-2017 across seven Indian hospitals were included. Conventional multiplex polymerase chain reaction for the genes encoding beta-lactamases such as extended-spectrum beta-lactamase (ESBL) and carbapenemase were screened. A subset of isolates (n = 133) of CP P. aeruginosa were genotyped by multilocus sequence typing (MLST) scheme.

RESULTS

Of the total 507 isolates, 15%, 40% and 20% were positive for genes encoding ESBLs, carbapenemases and ESBLs + carbapenemases, respectively, whilst 25% were negative for the β-lactamases screened. Amongst the ESBL genes, bla is the most predominant, followed by bla and bla, whilst bla and bla were the most predominant carbapenemases seen. However, regional differences were noted in the β-lactamases profile across the study sites. Genotyping by MLST revealed 54 different sequence types (STs). The most common are ST357, ST235, ST233 and ST244. Six clonal complexes were found (CC357, CC235, CC244, CC1047, CC664 and CC308). About 24% of total STs are of novel types and these were found to emerge from the high-risk clones.

CONCLUSION

This is the first large study from India to report the baseline data on the molecular resistance mechanisms and its association with genetic relatedness of CP P. aeruginosa circulating in Indian hospitals. bla- and bla-producing P. aeruginosa is the most prevalent carbapenemase seen in India. Majority of the isolates belongs to the high-risk international clones ST235, ST357 and ST664 which is a concern.

摘要

背景

铜绿假单胞菌是引起人类严重感染的最常见机会性病原体之一。碳青霉烯耐药负担特别高且呈上升趋势。关于印度医院中碳青霉烯耐药铜绿假单胞菌的分子机制及其克隆类型的信息非常少。本研究旨在监测β-内酰胺酶谱,并调查从印度不同医院收集的产碳青霉烯酶(CP)铜绿假单胞菌的遗传相关性。

材料与方法

纳入了2014年至2017年期间从印度七家医院收集的各种临床标本中分离出的507株非重复的碳青霉烯耐药铜绿假单胞菌。对编码β-内酰胺酶(如超广谱β-内酰胺酶(ESBL)和碳青霉烯酶)的基因进行常规多重聚合酶链反应筛选。通过多位点序列分型(MLST)方案对CP铜绿假单胞菌的一部分分离株(n = 133)进行基因分型。

结果

在总共507株分离株中,分别有15%、40%和20%的分离株编码ESBLs、碳青霉烯酶和ESBLs + 碳青霉烯酶的基因呈阳性,而25%的分离株对筛选的β-内酰胺酶呈阴性。在ESBL基因中,bla是最主要的,其次是bla和bla,而bla和bla是最主要的碳青霉烯酶。然而,研究地点之间的β-内酰胺酶谱存在区域差异。通过MLST进行基因分型显示有54种不同的序列类型(STs)。最常见的是ST357、ST235、ST233和ST244。发现了六个克隆复合体(CC357、CC235、CC244、CC1047、CC664和CC308)。约24%的总STs是新型类型,并且发现它们源自高风险克隆。

结论

这是印度第一项大型研究,报告了印度医院中循环的CP铜绿假单胞菌的分子耐药机制及其与遗传相关性的基线数据。产bla和bla的铜绿假单胞菌是印度最常见的碳青霉烯酶。大多数分离株属于高风险的国际克隆ST235、ST357和ST664,这令人担忧。

相似文献

1
Dominance of international high-risk clones in carbapenemase-producing : Multicentric molecular epidemiology report from India.产碳青霉烯酶菌中国际高风险克隆的优势:来自印度的多中心分子流行病学报告
Indian J Med Microbiol. 2018 Jul-Sep;36(3):344-351. doi: 10.4103/ijmm.IJMM_18_294.
2
Similar frequencies of Pseudomonas aeruginosa isolates producing KPC and VIM carbapenemases in diverse genetic clones at tertiary-care hospitals in Medellín, Colombia.哥伦比亚麦德林市三级医院不同遗传克隆中产 KPC 和 VIM 碳青霉烯酶的铜绿假单胞菌分离株的相似频率。
J Clin Microbiol. 2014 Nov;52(11):3978-86. doi: 10.1128/JCM.01879-14. Epub 2014 Sep 10.
3
Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons.来自希腊中部的产碳青霉烯酶铜绿假单胞菌:I类整合子的分子流行病学和基因分析
BMC Infect Dis. 2013 Oct 29;13:505. doi: 10.1186/1471-2334-13-505.
4
Molecular epidemiology of Pseudomonas aeruginosa clinical isolates from Korea producing β-lactamases with extended-spectrum activity.韩国产超广谱β-内酰胺酶的铜绿假单胞菌临床分离株的分子流行病学研究。
Diagn Microbiol Infect Dis. 2014 Jul;79(3):373-7. doi: 10.1016/j.diagmicrobio.2014.03.007. Epub 2014 Mar 17.
5
Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the region.在海湾合作委员会国家的选定医院中鉴定耐碳青霉烯铜绿假单胞菌:该地区高风险克隆的主导地位。
J Med Microbiol. 2018 Jun;67(6):846-853. doi: 10.1099/jmm.0.000730. Epub 2018 Apr 17.
6
Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying bla, bla, bla, bla and bla.西班牙产碳青霉烯酶铜绿假单胞菌:携带 bla、bla、bla、bla 和 bla 的高风险克隆株 ST175 和 ST244 的区域性传播
Int J Antimicrob Agents. 2020 Jul;56(1):106026. doi: 10.1016/j.ijantimicag.2020.106026. Epub 2020 May 22.
7
Dissemination of Metallo-β-Lactamase-Producing in Serbian Hospital Settings: Expansion of ST235 and ST654 Clones.在塞尔维亚医院环境中传播的产金属β-内酰胺酶:ST235 和 ST654 克隆的扩展。
Int J Mol Sci. 2023 Jan 12;24(2):1519. doi: 10.3390/ijms24021519.
8
Occurrence of VIM-4 metallo-β-lactamase-producing Pseudomonas aeruginosa in an Algerian hospital.阿尔及利亚一家医院中产VIM-4金属β-内酰胺酶的铜绿假单胞菌的出现。
J Infect Dev Ctries. 2019 Apr 30;13(4):284-290. doi: 10.3855/jidc.10679.
9
Molecular epidemiology of Pseudomonas aeruginosa isolated from infected ICU patients: a French multicenter 2012-2013 study.2012-2013 年法国多中心研究:感染 ICU 患者分离的铜绿假单胞菌的分子流行病学。
Eur J Clin Microbiol Infect Dis. 2019 May;38(5):921-926. doi: 10.1007/s10096-019-03519-w. Epub 2019 Mar 2.
10
Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.保加利亚医院分离的铜绿假单胞菌的分子流行病学和多药耐药机制。
Microb Drug Resist. 2013 Oct;19(5):355-61. doi: 10.1089/mdr.2013.0004. Epub 2013 Apr 21.

引用本文的文献

1
Genetic Diversity in Antimicrobial Resistance Determinants Among Pathogenic Pseudomonas aeruginosa in India.印度致病性铜绿假单胞菌抗菌药物耐药性决定因素的遗传多样性
Curr Microbiol. 2025 Mar 13;82(5):189. doi: 10.1007/s00284-025-04174-5.
2
Risk of Colonization with Multidrug-Resistant Gram-Negative Bacteria Among Travellers and Migrants: A Narrative Review.旅行者和移民中耐多药革兰氏阴性菌定植的风险:一项叙述性综述
Trop Med Infect Dis. 2025 Jan 18;10(1):26. doi: 10.3390/tropicalmed10010026.
3
High-risk clones harboring β-lactamases: 2024 update.
携带β-内酰胺酶的高危克隆:2024年更新
Heliyon. 2024 Dec 26;11(1):e41540. doi: 10.1016/j.heliyon.2024.e41540. eCollection 2025 Jan 15.
4
Burden and Management of Multi-Drug Resistant Organism Infections in Solid Organ Transplant Recipients Across the World: A Narrative Review.全球实体器官移植受者中多重耐药菌感染的负担和管理:一项叙述性综述。
Transpl Int. 2024 Jun 17;37:12469. doi: 10.3389/ti.2024.12469. eCollection 2024.
5
Antimicrobial Resistance Profiles of Pseudomonas aeruginosa in the Arabian Gulf Region Over a 12-Year Period (2010-2021).在过去 12 年(2010-2021 年)中,阿拉伯海湾地区铜绿假单胞菌的抗生素耐药性分析。
J Epidemiol Glob Health. 2024 Sep;14(3):529-548. doi: 10.1007/s44197-024-00191-y. Epub 2024 Jun 10.
6
Antimicrobial resistance heterogeneity among multidrug-resistant Gram-negative pathogens: Phenotypic, genotypic, and proteomic analysis.多重耐药革兰氏阴性病原体中抗菌药物耐药异质性:表型、基因型和蛋白质组学分析。
Proc Natl Acad Sci U S A. 2023 Aug 15;120(33):e2305465120. doi: 10.1073/pnas.2305465120. Epub 2023 Aug 7.
7
Successful Use of Cefepime-Zidebactam (WCK 5222) as a Salvage Therapy for the Treatment of Disseminated Extensively Drug-Resistant New Delhi Metallo-β-Lactamase-Producing Pseudomonas aeruginosa Infection in an Adult Patient with Acute T-Cell Leukemia.成功使用头孢吡肟-齐多夫定(WCK 5222)作为挽救疗法治疗急性 T 细胞白血病成年患者广泛耐药新德里金属β-内酰胺酶产生铜绿假单胞菌感染的播散性感染。
Antimicrob Agents Chemother. 2023 Aug;67(8):e0050023. doi: 10.1128/aac.00500-23. Epub 2023 Jun 14.
8
PorinPredict: Identification of OprD Loss from WGS Data for Improved Genotype-Phenotype Predictions of P. aeruginosa Carbapenem Resistance.孔蛋白预测:从全基因组测序数据中鉴定OprD缺失以改善铜绿假单胞菌碳青霉烯耐药性的基因型-表型预测
Microbiol Spectr. 2023 Jan 30;11(2):e0358822. doi: 10.1128/spectrum.03588-22.
9
Emergence and Transfer of Plasmid-Harbored in a Clinical Multidrug-Resistant Strain.临床多药耐药菌株中质粒携带基因的出现与转移
Microorganisms. 2022 Sep 11;10(9):1818. doi: 10.3390/microorganisms10091818.
10
New Variants of Pseudomonas High-Risk Clone ST233 Associated with an Outbreak in a Mexican Paediatric Hospital.与墨西哥一家儿科医院爆发疫情相关的铜绿假单胞菌高风险克隆ST233新变种
Microorganisms. 2022 Jul 29;10(8):1533. doi: 10.3390/microorganisms10081533.